Navigation Links
ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical,Model

are for a phase 2 clinical trial in multiple myeloma later this year".

Acceleron is developing therapeutics that addresses the clinical consequences of cancer, such as bone loss and/or muscle loss, as well as treatments that directly target the underlying tumor. Given the improving therapeutic outcomes leading to more cancer patients living longer with their disease, the frequency of secondary consequences of cancer is increasing.

About ACE-011

ACE-011, a novel bone anabolic agent currently in a phase 1 clinical trial, is a protein therapeutic based on the activin receptor IIA. In numerous preclinical models of bone loss, ACE-011 has demonstrated beneficial effects on both trabecular and cortical bone. ACE-011 increased bone mineral density, improved bone architecture, increased the mineral apposition and bone formation rates and improved bone mechanical strength. These effects have been demonstrated in therapeutic models of bone loss in which ACE-011 has stimulated bone formation - a significant unmet medical need that is underserved by current treatments for bone loss.

About Multiple Myeloma

Multiple myeloma is a malignancy of plasma cells in the bone marrow that disrupts normal bone marrow function. Myeloma cells invade and destroy the bone surrounding the marrow cavity leading to rapid and widespread osteoporosis and osteolytic bone lesions, resulting in fractures, vertebral compressions and bone pain. Intravenous bisphosphonates are the current standard of care, but significant unmet medical need remains since most patients will still have serious bone complications despite treatment. According to the International Myeloma Foundation, there are an estimated 750,000 people worldwide multiple myeloma. In the US and EU, there are approximately 80,000 myeloma patients whose disease has affected their bones.

About Acceleron Pharma

Acceleron is a privately held biopharmaceutical company committed to discover, develop,
'"/>




Page: 1 2 3

Related medicine technology :

1. Mayo Clinic News Release: Mayo Clinic-led Study Improves Breast Cancer Risk Prediction in Women with Atypia
2. Anastrozole (Arimidex) Improves Overall Survival in Postmenopausal Women with Early Breast Cancer Receiving Treatment with Tamoxifen
3. Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
4. Data Presented at SLEEP 2007 Shows VEC-162 Improves Sleep Onset and Maintenance vs. Placebo
5. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
6. Study Shows Velcade Plus Doxil Improves Survival in Previously Treated Patients With Multiple Myeloma
7. Adding Thalidomide to Standard Therapy Improves Survival in Newly Diagnosed Multiple Myeloma Patients Over Age 75
8. First-of-Its-Kind Study Shows Botox (Botulinum Toxin Type A) Significantly Improves Idiopathic Detrusor Overactivity (IDO) in Patients With Symptoms of Overactive Bladder
9. Newly Published Study Reveals Femara Improves Chances for Harder to Treat Early Breast Cancer Relapse in Postmenopausal Women
10. Once Daily, Extended-Release Ropinirole Improves Parkinsons Symptoms in Patients not Optimally Controlled With Levodopa
11. Keryx Biopharmaceuticals, Inc. Announces Positive Phase I and Phase II Data on KRX-0401 in Patients with Relapsed/Refractory Multiple Myeloma and Waldenstroms Macroglobulinemia
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: ACE Improves Multiple Myeloma Bone Disease Preclinical Model
(Date:7/2/2015)... SAN FRANCISCO , July 2, 2015  The ... www.tryloud.com ), the world,s first HIPAA compliant mobile app ... delivery of farm-to-table fresh medical marijuana, announced today that ... Unlike Eaze, Meadow and more than half ... in the last year, Loud Cannabis is unique in ...
(Date:7/2/2015)... , July 2, 2015 ... (Homofermentative & Heterofermentative), Species (Lactobacillus, Pediococcus & Enterococcus), Enzymes ... and Forecast to 2020", Silage Inoculants & Enzymes Market ... a CAGR of 4.0% from 2015 to 2020. ... igures spread through 194 P ...
(Date:7/2/2015)... , July 2, 2015  The Commission ... agreement with ASHP, an organization that represents pharmacists ... a provider of continuing education for recertification of ... track of geriatric programs for this purpose.  ASHP ... as authorized providers for the CCGP Professional Development ...
Breaking Medicine Technology:New Cannabis Delivery App Gets Product to Patient in Under 7 Minutes 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 2Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 3Silage Inoculants & Enzymes Market Worth $489.05 Million by 2020 4Commission for Certification in Geriatric Pharmacy Adds ASHP as Professional Development Program Provider 2
... DUBLIN, Calif., June 16 SuperGen Inc.,(Nasdaq: ... to the discovery, rapid,development and commercialization of ... announced at the 13th Congress of the,European ... its JAK2 kinase inhibitor, prevents tumor cell ...
... COGENT-1 Study of CGT-2168 Expands to Europe; Focus ... Gastrointestinal Side Effects of Antiplatelet Therapy, ... Pharmaceuticals,Inc. today announced that the first patient has ... 3 study of its novel combination medicine,CGT-2168. The ...
Cached Medicine Technology:SuperGen's JAK2 Inhibitor, SGI-1252, Inhibits in Vivo Tumor Cell Proliferation 2European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals 2
(Date:7/2/2015)... ... July 02, 2015 , ... When Walker Parking ... the University of Minnesota, they knew it would save the university energy and ... award-winning choice: the total energy savings after installation was an impressive 89 percent, ...
(Date:7/2/2015)... ... 2015 , ... With summer in full swing, Americans are flocking to Canada’s many lakes to ... for fishing in the world, and it’s easy to understand why. From the Pacific Northwest ... , Recreational fishing is a huge industry, and Americans make up the vast majority ...
(Date:7/2/2015)... ... July 02, 2015 , ... “ LIFX ” was featured on ... technology products available to consumers. Amanda Forstrom, a technology expert and special reporter for ... most versatile smart light bulbs on the market. , According to the U.S. Department ...
(Date:7/2/2015)... ... July 02, 2015 , ... Get ready ... SIGVARIS PERFORMANCE SOCKS. Since the socks were first introduced, they have rapidly been ... popularity has inspired four new, fun shades including: blue, lime, pink and red. ...
(Date:7/2/2015)... , ... July 02, 2015 , ... Six months ahead ... solo cross-country walk to raise awareness and money for the Pulmonary Hypertension Association ... arrive at PHA’s headquarters near Washington, D.C. by mid-September. He left Glasgow, Mont. yesterday ...
Breaking Medicine News(10 mins):Health News:Kenall’s TekDek™ Helps University Achieve Award-Winning Energy Savings in Parking Structure Lighting Retrofit 2Health News:The Most Versatile Smart Light Bulbs were featured on NewsWatch Television 2Health News:SIGVARIS is Sporting Four Brand New Colors in the Popular PERFORMANCE SOCK Product Line 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 2Health News:79-Year-old ‘Pacing Parson’ Passes 1,000-Mile Mark in Cross-Country Walk for Pulmonary Hypertension Association 3
... to have developed a device to facilitate keyhole surgery for ... as a breakthrough in spinal treatment. // ... neurosurgery at King George's Medical University (KGMU), has developed a ... the complicated and painful procedures practised so far. ...
... XR drug for attention deficit hyperactivity disorder (ADHD) needs to ... the US FDA regulators. // ,It has ... about the side effects of the drug such as hallucinations ... with no identifiable risk factors. The FDA had prepared a ...
... was caught in the throes of a bizarre incident that threw ... whole of the ICU was held hostage by a patient’s relative. ... that his child, who was on the road to recovery, not ... ,The police was informed, but they did not react immediately. ...
... hand, foot and mouth disease (HFMD). Eight children have already ... situation the state government has worked out a series of preventive ... in five areas of the state, bringing the total number to ... to spread to the interior rural areas. Cases are seen at ...
... teenager to death. Disturbing images of this violent act were captured// ... truth, saying it was a natural death, but upon a second ... of 14, had been brutally beaten to death. This incident and ... demand in the U.S to close down all the boot camps. ...
... of AGD Impact, the newsmagazine of the Academy of ... way to correct crooked teeth. Orthodontics, the branch of ... help in improving the "stability, function, and health of ... feel better about themselves,” said AGD spokesperson James G. ...
Cached Medicine News:Health News:New Device Developed For Treating Cervical Spondylitis 2Health News:Malaysia to Beef in Medical Care to Fight against HFMD 2
Used for emergency airway access when conventional endotracheal intubation cannot be performed. Supplied sterile in peel-open packages. Intended for one-time use....
... Standard/Conventional Blade. Stainless Steel. Lamp supplied ... tradition of high quality standard incandescent ... blades have been continually refined through ... over to minimize maintenance requirements. They ...
... Rusch Snap-Light™ laryngoscope blades are designed ... diameter fiber optic bundle can be removed ... hard to reach areas. Our unique snap-on ... The bright focused blades are interchangeable with ...
... Greenspec Laryngoscopes are a high quality ... of bringing greater standardization to fiberoptic laryngoscopes. ... fiberoptic and indicates it's ability to interconnect ... Fiberoptic light offers a cool, bright and ...
Medicine Products: